Elsevier logo

Publisher: Elsevier

Volume 18, Number 5, September 1996
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial comment
pp. 789-789(1)
Author: Krosnick A.

Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis
pp. 790-796(7)
Author: Chervinsky P.

The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
pp. 797-810(14)
Authors: Oparil S.; Dyke S.; Harris F.; Kief J.; James D.; Hester A.; Fitzsimmons S.

Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media
pp. 811-820(10)
Authors: Blumer J.L.; Forti W.P.; Summerhouse T.L.

Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life
pp. 821-832(12)
Authors: Laibovitz R.; Boyle J.; Snyder E.; Strohmaier K.; Adamsons I.

Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube
pp. 833-842(10)
Authors: Chun A.H.C.; Shi H.H.; Achari R.; Dennis S.; Cavanaugh J.H.

Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain
pp. 843-852(10)
Authors: Englert R.; Fontanesi G.; Muller P.; Ott H.; Rehn L.; Silva H.

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study
pp. 853-863(11)
Authors: Heinonen T.M.; Stein E.; Weiss S.R.; McKenney J.M.; Davidson M.; Shurzinske L.; Black D.M.

Usefulness of low-dose, once-daily quinapril as monotherapy for patients with hypertension
pp. 864-873(10)
Authors: Olvera S.; Alcocer L.; Novoa G.

Pharmaceutical economics & health policy - Editorial comment
pp. 876-876(1)
Author: Sclar D.A.

The relative community burden of otitis media and varicella
pp. 877-886(10)
Authors: Yawn B.P.; Yawn R.A.; Lydick E.

A review of health-related quality-of-life measures used in end-stage renal disease
pp. 887-938(52)
Authors: Edgell E.T.; Coons S.J.; Carter W.B.; Kallich J.D.; Mapes D.; Damush T.M.; Hays R.D.

A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma
pp. 939-952(14)
Authors: Thomas P.; Ross R.N.; Farrar J.R.

A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx(R)) versus intravenous phenytoin (Dilantin(R)) in hospital emergency departments
pp. 953-966(14)
Authors: Marchetti A.; Magar R.; Fischer J.; Sloan E.; Fischer P.

Editorial comment
pp. 968-968(1)
Author: McGhan W.F.

The future of pharmacoeconomics: bridging science and practice
pp. 969-978(10)
Author: Drummond M.F.

Evaluating quality-of-life and health status instruments: development of scientific review criteria
pp. 979-992(14)
Authors: Lohr K.N.; Aaronson N.K.; Alonso J.; Audrey Burnam M.; Patrick D.L.; Perrin E.B.; Roberts J.S.

A cost density analysis of benign prostatic hyperplasia
pp. 993-1004(12)
Authors: Lanes S.F.; Sulsky S.; Walker A.M.; Isen J.; Grier C.E.; Edelman Lewis B.; Dreyer N.A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A